Discounted Cash Flow
Alterity Therapeutics Ltd. ADR
—
—
⚠ Cash flow predictability 54/100 (moderate) —
FCF YoY std dev 52%,
net income 55% (full history)
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | — | — | — | — | — |
| 2017 | — | $-5.4m | $-4.2m | — | $-1.41 |
| 2018 | $144.5k | $-5.9m (-9.6%) | $-4.5m (-6.5%) | -4108.8% | $-1.55 (-9.9%) |
| 2019 | $78.0k (-46.0%) | $-8.9m (-49.3%) | $-10.0m (-123.4%) | -11367.3% (-176.7%) | $-2.00 (-29.0%) |
| 2020 | $12.3k (-84.2%) | $-9.7m (-9.1%) | $-6.8m (32.4%) | -78616.6% (-591.6%) | $-1.50 (25.0%) |
| 2021 | $14.9k (20.8%) | $11.0m (213.8%) | $-12.5m (-83.8%) | 74044.1% (194.2%) | $-0.90 (40.0%) |
| 2022 | $1.8k (-87.9%) | $9.2m (-16.1%) | $-8.9m (28.8%) | 513061.5% (592.9%) | $-0.53 (41.1%) |
| 2023 | $11.8k (556.4%) | $9.9m (7.5%) | $-14.4m (-62.4%) | 84001.7% (-83.6%) | $-0.57 (-7.5%) |
| 2024 | $192.9k (1533.1%) | $-13.7m (-238.2%) | $-9.1m (37.1%) | -7107.3% (-108.5%) | $-0.52 (8.8%) |
| 2025 | $320.7k (66.3%) | $-8.7m (36.7%) | $-8.2m (9.2%) | -2706.7% (61.9%) | $-0.19 (63.5%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
SEC filings report in AUD. Values above are converted to USD for comparison with the US-listed share price.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Net debt deduction: —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.